Shares of AbbVie Inc. ABBV inched 0.60% higher to $201.68 Tuesday, on what proved to be an all-around great trading session ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $203.55 which represents a decrease of $-0.32 or -0.16% from the prior close of $203.87. The stock opened at $204.37 and touched a ...

EvolveImmune Therapeutics Inc., a Branford-based bioscience company developing therapeutics to overcome cancer cell ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

UChicago Medicine has received a $75 million gift from the AbbVie Foundation — a nonprofit focused on advancing health equity — to support the development of its new 575,000-square-foot cancer ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. A $75 million donation from the AbbVie Foundation will help University of Chicago Medicine build its new cancer ...

Learn more about the new cancer pavilion for UChicago, the leaders of which hope will one day be a leading institution for ...

The foundation donation will go toward construction of UChicago Medicine's $815 million freestanding cancer care center in ...

AbbVie’s Humira missed Wall Street’s expectations in the third quarter but Skyrizi and Rinvoq’s continuing outperformance ...

Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations ...